Nutritional program to reduce frailty in people waiting for a liver transplant

Impact of Nutritional Management on the Frailty of Patients Waiting for Liver Transplantation (Via the LFI Tool)

Not applicable Interventional Hospices Civils de Lyon · NCT06911619

This trial will try a targeted nutritional management program to see if it reduces frailty in adults with cirrhosis who are on the liver transplant waiting list.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment210 (estimated)
Ages18 Years and up
SexAll
SponsorHospices Civils de Lyon Academic / other
Locations1 site (Lyon)
Trial IDNCT06911619 on ClinicalTrials.gov

What this trial studies

Adults listed for liver transplantation at Hospices Civils de Lyon who are frail or sarcopenic will be offered a dietary management intervention versus usual care. Frailty will be measured using the Liver Frailty Index (LFI), which combines bedside grip strength, chair stand, and balance tests to produce a reproducible score. Participants with an initial LFI below the frailty threshold are excluded and those unable to perform the physical tests are not eligible. The trial compares change in frailty and nutritional status between the dietary management group and the no-dietary-management group during the pre-transplant waiting period.

Who should consider this trial

Good fit: Adults (≥18) who are registered on the liver transplant waiting list at Croix Rousse Hospital with cirrhosis and an LFI indicating frailty (LFI ≥ 3.2), who can perform the physical tests and provide informed consent, are ideal candidates.

Not a fit: Patients with an initial LFI indicating robustness (LFI < 3.2), those unable to perform the LFI exercises, patients in intensive care, pregnant or lactating women, or those under legal/psychiatric restrictions are unlikely to benefit or are ineligible.

Why it matters

Potential benefit: If successful, the nutritional program could reduce frailty and sarcopenia before transplant, potentially lowering complications and improving transplant outcomes.

How similar studies have performed: The Liver Frailty Index was validated by Lai et al. in 2017 for measuring frailty in transplant candidates, but evidence that nutrition interventions reliably reverse frailty in cirrhosis is limited and results have been mixed.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient aged ≥ 18 years
* Patient registered on the waiting list for Hepatic Transplantation in the Transplantation center of the Croix Rousse Hospital (GHN), Hospices Civils de Lyon
* Dated and signed an informed consent
* Affiliated to a social security scheme or beneficiary of a similar scheme

Exclusion Criteria:

* Patient hospitalized in intensive care
* Patient with initial LFI test result \< to 3.2, that is considered as "robust".
* Patient unable to perform LFI exercises (chronic or acute motor disability in lower or upper limbs)
* Pregnant, parturient or lactating women
* Persons deprived of liberty by a judicial or administrative decision
* Persons under psychiatric care
* Persons admitted to a health or social institution for purposes other than research
* Adults subject to a legal protection measure (guardianship, curatorship)
* Inability to understand protocol information
* Subject participating in another interventional research including an ongoing exclusion period at inclusion

Where this trial is running

Lyon

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions FragilityCirrhosisHepatic TransplantationUndernutritionnutrition
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.